Evidence map›Paper›PMID 26347101›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2015

Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al.

S Gillessen, S Fanti, A Omlin, panelists and authors of APCCC

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Early biochemical and radiographic response after one cycle of [European journal of nuclear medicine and molecular imaging · 2023
    Article
  2. Whole Body MRI and oncology: recent major advances.The British journal of radiology · 2018
    Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

S GillessenDepartment of Oncology/Hematology, Kantonsspital St Gallen, St Gallen, Switzerland silke.gillessen@kssg.ch.
S FantiDepartment of Nuclear Medicine, Policlinico S. Orsola-University of Bologna, Bologna, Italy.
A OmlinDepartment of Oncology/Hematology, Kantonsspital St Gallen, St Gallen, Switzerland.
panelists and authors of APCCC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAndrogen AntagonistsAntineoplastic Agents, HormonalBone Density Conservation AgentsHumansMaleProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantTaxoidsAndrogen AntagonistsAntineoplastic Agents, HormonalBone Density Conservation AgentsTaxoids

Identifiers

PMID26347101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.